An Adaptive Machine Learning Triage Framework for Predicting Alzheimer's Disease Progression

Accurate predictions of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) can enable effective personalized therapy. While cognitive tests and clinical data are routinely collected, they lack the predictive power of PET scans and CSF biomarker analysis, which are prohibitively expensive to obtain for every patient. To address this cost-accuracy dilemma, we design a two-stage machine learning framework that selectively obtains advanced, costly features based on their pre...